Literature DB >> 16525984

Reductions in blood loss with use of a bipolar sealer for hemostasis in primary total knee arthroplasty.

German A Marulanda1, Phillip S Ragland, Thorsten M Seyler, Michael A Mont.   

Abstract

Fifty primary total knee arthroplasties were performed in a prospective, randomized study comparing the use of a bipolar sealer device versus conventional electrocautery as the method of hemostasis. Both cohorts were evaluated for intraoperative blood loss, transfusion rate, postoperative drainage, hemoglobin levels, and Knee Society scores. A significant reduction in postoperative and total blood loss was found (p = 0.05 and p = 0.02, respectively), as well as an absence of tissue charring and smoke production in the bipolar sealer group. No difference in knee scores was found between both cohorts. These results suggest that use of this bipolar sealing device is at least as effective as standard cautery devices and can reduce blood loss, tissue damage, and smoke production in total knee arthroplasties without affecting the results.

Entities:  

Mesh:

Year:  2005        PMID: 16525984

Source DB:  PubMed          Journal:  Surg Technol Int        ISSN: 1090-3941


  10 in total

1.  The use of harmonic scalpel in spinal surgery with contraindication to the use of monopolar electrocautery: a case report in a 14-year-old girl with a primary generalized dystonia and a 100° thoracic scoliosis.

Authors:  Benjamin Bouyer; Manon Bachy; Anne-Isabelle Vermesch; Diane Doummar; Philippe Coubes; Raphaël Vialle
Journal:  Childs Nerv Syst       Date:  2012-04-29       Impact factor: 1.475

2.  The Aquamantys(®) system improves haemostasis and pneumostasis in open decortication for thoracic empyema.

Authors:  Edward J Caruana; Jakub Kadlec; Swetha Iyer; Aleksander Mani; Piergiorgio Solli; Marco Scarci
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

3.  Bipolar Sealers and Tourniquet Use Have Similar Outcomes in Total Knee Arthroplasty.

Authors:  Stephen G Zak; Nishanth Muthusamy; Chelsea Sicat; James Slover; Ran Schwarzkopf
Journal:  Indian J Orthop       Date:  2022-08-04       Impact factor: 1.033

Review 4.  Optimizing Intraoperative Blood Management for One-Stage Bilateral Total Knee Arthroplasty.

Authors:  Vasileios Soranoglou; Lazaros A Poultsides; Georgios K Triantafyllopoulos; Ivan De Martino; Stavros G Memtsoudis; Thomas P Sculco
Journal:  HSS J       Date:  2017-12-07

5.  Effects of tranexamic acid and bipolar sealer alone or in combination in primary total knee arthroplasty: a prospective, randomized, controlled trial.

Authors:  Alexandru Seviciu; Irwin Gross; Samreen Fathima; Stephen M Walsh
Journal:  Arthroplast Today       Date:  2016-03-31

6.  Is bipolar sealer superior than standard electrocautery for blood loss control after primary total knee arthroplasty: A meta-analysis.

Authors:  Xinxin Chen; Wenhui Yang; Xiao Wang
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

7.  Radiofrequency bipolar hemostatic sealer reduces blood loss, transfusion requirements, and cost for patients undergoing multilevel spinal fusion surgery: a case control study.

Authors:  Steven M Frank; Jack O Wasey; Ian M Dwyer; Ziya L Gokaslan; Paul M Ness; Khaled M Kebaish
Journal:  J Orthop Surg Res       Date:  2014-07-05       Impact factor: 2.359

8.  Bipolar sealer not superior to standard electrocautery in primary total hip arthroplasty: a meta-analysis.

Authors:  Yang Yang; Li-Chao Zhang; Fei Xu; Jia Li; Yong-Ming Lv
Journal:  J Orthop Surg Res       Date:  2014-10-10       Impact factor: 2.359

9.  Saline-coupled bipolar sealing in simultaneous bilateral total knee arthroplasty.

Authors:  Atul F Kamath; Daniel C Austin; Peter B Derman; R Carter Clement; Jonathan P Garino; Gwo-Chin Lee
Journal:  Clin Orthop Surg       Date:  2014-08-05

10.  Postoperative anaemia might be a risk factor for postoperative delirium and prolonged hospital stay: A secondary analysis of a prospective cohort study.

Authors:  Julius Valentin Kunz; Claudia D Spies; Anna Bichmann; Miriam Sieg; Anika Mueller
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.